Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
26.67
+0.26 (0.98%)
At close: Jun 24, 2026, 4:00 PM EDT
26.67
0.00 (0.00%)
After-hours: Jun 24, 2026, 5:44 PM EDT
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.48 billion as of June 24, 2026. Its market cap has increased by 163.09% in one year.
Market Cap
1.48B
Enterprise Value
1.18B
1-Year Change
163.09%
Ranking
Category
Stock Price
$26.67
Market Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.48B, an increase of 115.41%. That is a compound annual growth rate of 73.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 1.48B | -25.96% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novavax | 1.48B |
| Ascentage Pharma Group International | 1.48B |
| Fortrea Holdings | 1.47B |
| Damora Therapeutics | 1.47B |
| Savara | 1.44B |
| Hemab Therapeutics Holdings | 1.40B |
| Avalyn Pharma | 1.38B |
| Aktis Oncology | 1.37B |